BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14993501)

  • 1. Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy.
    Jorna FH; Tobé TJ; Huisman RM; de Jong PE; Plukker JT; Stegeman CA
    Nephrol Dial Transplant; 2004 May; 19(5):1168-73. PubMed ID: 14993501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL; Chan TT; Ho YW; Lam SH
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.
    Evenepoel P; Kuypers D; Maes B; Messiaen T; Vanrenterghem Y
    Acta Otorhinolaryngol Belg; 2001; 55(2):177-86. PubMed ID: 11441477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.
    Lomonte C; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Basile C
    J Nephrol; 2006; 19(1):70-6. PubMed ID: 16523429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
    Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
    Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A; Fahmi M; ElSayed M; Aboud O; Asim M
    Transplant Proc; 2004; 36(6):1815-7. PubMed ID: 15350484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
    Drakopoulos S; Koukoulaki M; Apostolou T; Pistolas D; Balaska K; Gavriil S; Hadjiconstantinou V
    Am J Surg; 2009 Aug; 198(2):178-83. PubMed ID: 19217601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high prevalence of alexithymia in hemodialyzed patients with secondary hyperparathyroidism unsuppressed by medical therapy is cured by parathyroidectomy.
    De Santo RM; Livrea A; De Santo NG; Conzo G; Bilancio G; Celsi S; Cirillo M
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S64-70. PubMed ID: 20797574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):92-5. PubMed ID: 15772929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease.
    Schaefer B; Schlosser K; Wühl E; Schall P; Klaus G; Schaefer F; Schmitt CP
    Nephrol Dial Transplant; 2010 Aug; 25(8):2590-5. PubMed ID: 20181803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain].
    Górriz JL; Sancho A; Pallardó LM; Amoedo ML; Martín M; Sanz P; Barril G; Selgas R; Salgueira M; Palma A; de la Torre M; Ferreras I
    Nefrologia; 2002; 22(1):49-59. PubMed ID: 11987685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism: a seven-year follow-up.
    Juergensen PH; Cooper K; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1998; 14():188-90. PubMed ID: 10649721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
    Stracke S; Keller F; Steinbach G; Henne-Bruns D; Wuerl P
    Nephron Clin Pract; 2009; 111(2):c102-9. PubMed ID: 19142022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group.
    Tokuyama K; Iseki K; Yoshi S; Yoshihara K; Nishime K; Uehara H; Tozawa M; Wake T; Arakaki M; Fukiyama K
    Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):309-13. PubMed ID: 8741393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.
    Saunders RN; Karoo R; Metcalfe MS; Nicholson ML
    Postgrad Med J; 2005 Apr; 81(954):255-8. PubMed ID: 15811891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience.
    Marrón B; Ortiz A; de Sequera P; Martín-Reyes G; de Arriba G; Lamas JM; Martínez Ocaña JC; Arrieta J; Martínez F;
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii51-5. PubMed ID: 16825262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.
    Lin HC; Chen CL; Lin HS; Chou KJ; Fang HC; Liu SI; Hsu CY; Huang WC; Huang CW; Huang CK; Chang TY; Chang YT; Lee PT
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):508-15. PubMed ID: 24102421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.